Green algae as a platform to express therapeutic proteins

Area of Science:

• Biotechnology
• Biopharmaceuticals
• Molecular Biology

Background:

• Recombinant protein drugs have been crucial in modern medicine for thirty years.
• High production costs, especially from mammalian cells, limit the widespread use of these therapies.
• Developing cost-effective protein expression systems is a key research and development priority.

Purpose of the Study:

• To explore alternative protein expression systems for reducing the cost of recombinant protein production.
• To identify systems that maintain the therapeutic efficacy of recombinant proteins.
• To evaluate eukaryotic unicellular green algae as a potential solution for cost-effective recombinant protein manufacturing.

Main Methods:

• Investigated the potential of eukaryotic unicellular green algae as a host for recombinant protein expression.
• Assessed the feasibility of using algae to overcome the cost barriers associated with traditional systems.
• Focused on maintaining high-level therapeutic activities of proteins produced in this novel system.

Main Results:

• Eukaryotic unicellular green algae present a viable alternative for recombinant protein production.
• This system has the potential to significantly reduce manufacturing costs compared to existing methods.
• The therapeutic activities of recombinant proteins can be preserved using this expression platform.

Conclusions:

• Green algae offer a promising and cost-effective platform for producing therapeutic recombinant proteins.
• This approach addresses the long-standing challenge of high production costs in biopharmaceuticals.
• Further research into algae-based expression systems could revolutionize biopharmaceutical manufacturing.